$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
出现不良反应如何调整他泽司他(tazemetostat)的剂量?
2025-10-19 11:44:20
Check Details
利妥昔单抗多少钱,怎么购买?
2025-10-19 11:44:20
Check Details
泽布替尼的适应症,用法用量及剂量调整?
2025-10-19 11:44:20
Check Details
泽布替尼治疗套细胞淋巴瘤(MCL)的效果如何?
2025-10-19 11:44:20
Check Details
厄布利塞(umbralisib)不良反应的剂量调整以及注意事项?
2025-10-19 11:44:20
Check Details
泽布替尼(zanubrutinib)治疗一个月费用?
2025-10-19 11:44:20
Check Details
泽布替尼(zanubrutinib)的功效与作用及副作用?
2025-10-19 11:44:20
Check Details
维奈克拉不良反应剂量调整方法?
2025-10-19 11:44:20
Check Details
利妥昔单抗注射液2024年多少钱一盒?
2025-10-19 11:44:20
Check Details
阿卡替尼(Acalabrutinib)的功效与作用及副作用?
2025-10-19 11:44:20
Check Details
伐美妥司他(Valemetostat)的用法用量及药物相互作用是什么?
2025-10-19 11:44:20
Check Details
他泽司他国内一瓶多少钱?
2025-10-19 11:44:20
Check Details
1
2
...
1280
1281
1282
1283
1284
1285
1286
...
4157
4158
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
2
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
3
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
4
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
5
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
6
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
7
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
8
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
9
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
10
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
11
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
12
Chemical Structure of Capivasertib: A Novel AKT Inhibitor